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Abstract 
Background: The microtubule assembly inhibitor nocodazole has been shown to trigger 
caspase-independent mitotic death and caspase dependent apoptosis. Similar to apoptosis 
of nucleated cells, erythrocytes may undergo eryptosis, the suicidal erythrocyte death 
characterized by cell shrinkage and cell membrane scrambling with phosphatidylserine 
translocation to the erythrocyte surface. Stimulators of eryptosis include increase of cytosolic 
Ca2+ activity ([Ca2+]i), oxidative stress and ceramide. The present study explored, whether and 
how nocodazole induces eryptosis. Methods: Flow cytometry was employed to determine 
phosphatidylserine exposure at the cell surface from annexin-V-binding, cell volume from 
forward scatter, [Ca2+]i from Fluo3-fluorescence, the abundance of reactive oxygen species 
(ROS) from 2′,7′-dichlorodihydrofluorescein (DCF) diacetate dependent fluorescence as well as 
ceramide surface abundance utilizing specific antibodies. Tubulin abundance was quantified 
by TubulinTracker™ Green reagent and visualized by confocal microscopy. Results: A 48 
hours exposure of human erythrocytes to nocodazole (≥ 30 µg/ml) significantly increased 
the percentage of annexin-V-binding cells without significantly modifying average forward 
scatter. Nocodazole significantly increased Fluo3-fluorescence, significantly increased 
DCF fluorescence and significantly increased ceramide surface abundance. The effect of 
nocodazole on annexin-V-binding was significantly blunted, but not abolished by removal 
of extracellular Ca2+ and was not modified in the presence of Caspase 3 inhibitor zVAD (1 
µM). Nocodazole treatment reduced the content of total tubulin. Conclusions: Nocodazole 
triggers cell shrinkage and phospholipid scrambling of the erythrocyte cell membrane, an 
effect in part due to stimulation of Ca2+ entry, oxidative stress and ceramide.
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IntroductionNocodazole interferes with microtubule assembly [1-14] thus interfering with mitosis due to formation of multipolar spindles [15, 16] and leading to cell cycle arrest in G2/M [8, 17-19]. Moreover, nocodazole causes cellular bulging and/or bending [20]. By interacting with microtubule function [21] nocodazole or related substances trigger caspase-independent mitotic death [22] or caspase dependent apoptosis [2, 5, 7, 10, 13, 16, 17, 23-28]. The triggering of apoptosis involves downregulation of mTOR [29], inactivation of the antiapoptotic Bcl-2 [2, 4, 23, 29] and mitochondrial depolarization [23]. Nocodazole is thus effective against malignancy [2, 5, 14, 15, 17, 21]. On the other hand, nocodazole counteracts TNF-α-induced activation of the mitogen-activated protein kinase p38 [30].Similar to apoptosis of nucleated cells, erythrocytes may enter eryptosis [31], the suicidal death of erythrocytes characterized by cell shrinkage [32] and cell membrane scrambling with phosphatidylserine translocation to the cell surface [31]. Triggers of eryptosis include increase of cytosolic Ca2+ activity ([Ca2+]i), ceramide [33], oxidative stress [31], energy 
depletion [31] activated caspases [34, 35], stimulated activity of casein kinase 1α, Janus-activated kinase JAK3, protein kinase C, and p38 kinase [31], as well as impaired activity of AMP activated kinase AMPK, cGMP-dependent protein kinase, PAK2 kinase, mitogen- and stress-activated kinase MSK1/2 and sorafenib/sunitinib sensitive kinases [31, 36]. The present study explored whether nocodazole induces eryptosis. To this end, human erythrocytes from healthy volunteers were treated with nocodazole and phosphatidylserine surface abundance, cell volume, [Ca2+]i, reactive oxygen species (ROS) and ceramide abundance determined by flow cytometry. 
Materials and Methods 
Erythrocytes, solutions and chemicalsFresh Li-Heparin-anticoagulated blood samples were kindly provided by the blood bank of the University of Tübingen. The study is approved by the ethics committee of the University of Tübingen (184/2003 V). The blood was centrifuged at 120 g for 20 min at 21°C and the platelets and leukocytes-containing supernatant was disposed. Erythrocytes were incubated in vitro at a hematocrit of 0.4% in Ringer solution containing (in mM) 125 NaCl, 5 KCl, 1 MgSO4, 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES; pH 7.4), 5 glucose, 1 CaCl2, at 37°C for 48 h. Where indicated, erythrocytes were exposed to nocodazole (Sigma Aldrich, Hamburg, Germany) at the indicated concentrations.
Annexin-V-binding and forward scatter After incubation under the respective experimental condition, 100 µl cell suspension was washed in Ringer solution containing 5 mM CaCl2 and then stained with Annexin-V-FITC (1:200 dilution; ImmunoTools, Friesoythe, Germany) in this solution at 37°C for 20 min under protection from light. The annexin-V abundance at the erythrocyte surface was subsequently determined on a FACS Calibur (BD, Heidelberg, Germany). A dot plot of forward scatter (FSC) vs. side scatter (SSC) was set to linear scale for both parameters. The threshold of forward scatter was set at the default value of “52”.
Intracellular Ca2+After treatment, erythrocytes were washed in Ringer solution and then loaded with 5 µM Fluo-3/AM (Biotium, Hayward, USA) in Ringer solution. The cells were incubated at 37°C for 30 min and washed once in Ringer solution. The Fluo-3/AM-loaded erythrocytes were resuspended in 200 µl Ringer. Then, Ca2+-
dependent fluorescence intensity was measured with an excitation wavelength of 488 nm and an emission wavelength of 530 nm on a FACS Calibur (BD, Heidelberg, Germany).
Measurement of hemolysis For the determination of hemolysis, the samples were centrifuged (10 min at 2000 rpm, room temperature) and the supernatants were collected. As a measure of hemolysis, the hemoglobin (Hb) 
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concentration of the supernatant was determined photometrically at 405 nm. The absorption of the 
supernatant of erythrocytes lysed in distilled water was defined as 100% hemolysis.
Reactive oxidant species (ROS) 
Oxidative stress was determined utilizing 2’,7’-dichlorodihydrofluorescein diacetate (DCFDA). After incubation, a 100 µl suspension of erythrocytes was washed in Ringer solution and then stained with DCFDA 
(Sigma, Schnelldorf, Germany) in PBS containing DCFDA at a final concentration of 10 µM. Erythrocytes were incubated at 37°C for 30 min in the dark and then washed in PBS. The DCFDA-loaded erythrocytes 
were resuspended in 200 µl Ringer solution, and ROS-dependent fluorescence intensity was measured at an excitation wavelength of 488 nm and an emission wavelength of 530 nm on a FACS Calibur (BD).
Ceramide abundanceFor the determination of ceramide, a monoclonal antibody-based assay was used. After incubation, cells were stained for 1 hour at 37°C with 1 µg/ml anti ceramide antibody (clone MID 15B4, Alexis, Grünberg, Germany) in PBS containing 0.1% bovine serum albumin (BSA) at a dilution of 1:10. The samples were 
washed twice with PBS-BSA. Subsequently, the cells were stained for 30 minutes with polyclonal fluorescein 
isothiocyanate (FITC) conjugated goat anti-mouse IgG and IgM specific antibody (Pharmingen, Hamburg, Germany) diluted 1:50 in PBS-BSA. Unbound secondary antibody was removed by repeated washing with 
PBS-BSA. The samples were then analyzed by flow cytometric analysis with an excitation wavelength of 488 nm and an emission wavelength of 530 nm.
Tubulin stainingFor studying the effect of nocodazole on tubulin in human erythrocytes TubulinTracker™ Green 
reagent (Oregon Green® 488 Taxol; bis-acetate, Thermo Fisher Scientific, MA, USA) was used. Briefly, treated samples were stained with TubulinTracker (250 nM) for 30 min in the dark at 37°C. The erythrocytes were 
washed twice and finally resuspended in 200 μl Ringer solution containing 5 mM CaCl2. For flow cytometry, 
TubulinTracker-dependent fluorescence of the samples was measured with an excitation wavelength of 488 nm and an emission wavelength of 530 nm on a FACS Calibur (BD). For confocal microscopy, 60 μl of each sample were spread onto a glass slide and dried for 15 minutes at RT. The slides were covered with PROlong Gold antifade reagent (Invitrogen, Darmstadt Germany). Images were taken on a Zeiss LSM 5 EXCITER confocal laser-scanning microscope or with phase light (Carl Zeiss MicroImaging, Germany) with a water 
immersion Plan-Neofluar 63/1.3 NA DIC. 
Statistics
Data are expressed as arithmetic means ± SEM. As indicated in the figure legends, statistical analysis was made using ANOVA with Tukey’s test as post-test and t test as appropriate. n denotes the number of different erythrocyte specimens studied. Since different erythrocyte specimens used in distinct experiments are differently susceptible to triggers of eryptosis, the same erythrocyte specimens have been used for control and experimental conditions.
ResultsThe present study aimed to possibly disclose an effect of nocodazole on eryptosis, the suicidal erythrocyte death characterized by cell shrinkage and cell membrane scrambling with phosphatidylserine translocation to the cell surface. In order to identify phosphatidylserine exposing erythrocytes the erythrocytes were incubated with annexin-V which tightly binds 
to surface phosphatidylserine. Annexin-V abundance was quantified by flow cytometry. The measurements were made following a 48 hours incubation in Ringer solution without or with nocodazole (15 - 60 µg/ml). As illustrated in Fig. 1, a 48 hours exposure to nocodazole increased the percentage of phosphatidylserine exposing erythrocytes, an effect reaching 
statistical significance at 30 µg/ml nocodazole. 
In order to estimate erythrocyte volume, forward scatter was determined utilizing flow cytometry following a 48 hours incubation in Ringer solution without or with nocodazole 
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Fig. 1. Effect of nocodazole on phosphatidylserine exposure. A. Original histogram of annexin-V-binding of erythrocytes following exposure for 48 hours to Ringer solution with solvent DMSO (grey area) and with presence of 60 µg/ml nocodazole (black line). B. Arithmetic means ± SEM (n = 8) of the percentage of an-nexin-V-binding erythrocytes (black bars) following incubation for 48 hours to Ringer solution without or 
with presence of nocodazole (15 - 60 µg/ml). ***(p<0.001) indicates significant difference from the absence of nocodazole (ANOVA).
Fig. 2. Effect of nocodazole on erythrocyte forward scatter. A. Original histogram of forward scatter of eryth-rocytes following exposure for 48 hours to Ringer solution with solvent DMSO (grey area) and with pres-ence of 60 µg/ml nocodazole (black line). B. Arithmetic means ± SEM (n = 8) of the erythrocyte forward scatter (FSC) following incubation for 48 hours to Ringer solution without (white bar) or with (black bars) nocodazole (15 - 60 µg/ml). C. Arithmetic means ± SEM (n = 8) of the percentage erythrocytes with forward scatter (FSC) < 200 following incubation for 48 hours to Ringer solution without (white bar) or with (black bars) nocodazole (15 - 60 µg/ml). D. Arithmetic means ± SEM (n = 8) of the percentage erythrocytes with forward scatter (FSC) > 800 following incubation for 48 hours to Ringer solution without (white bar) or 
with (black bars) nocodazole (15 - 60 µg/ml). *(p<0.05),***(p<0.001) indicate significant difference from the absence of nocodazole (ANOVA).
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(15 – 60 µg/ml). As shown in Fig. 2, at none of the applied concentrations, nocodazole had a 
significant effect on average erythrocyte forward scatter. Close inspection of Fig. 2A reveals, however, that exposure of erythrocytes to nocodazole was followed by an increase of the percentage of both small (Fig. 2C) and large (Fig. 2D) erythrocytes, alterations reaching 
significance at nocodazole concentrations of 60 µg/ml. Hemolysis was estimated from the hemoglobin concentration in the supernatant which was determined by photometry. As a result, following a 48 hours incubation, the percentage of hemolytic erythrocytes was similar in the absence of nocodazole (3.4 ± 0.2% n = 12) and in the presence of 15 µg/ml (4.4 ± 0.2% n = 12) or 30 µg/ml (4.7 ± 0.2% n = 12) nocodazole. 
Exposure to 60 µg/ml nocodazole was, however, followed by a significant increase of hemolysis (11.1 ± 0.9% n = 12).Cytosolic Ca2+ activity ([Ca2+]i) was determined by Fluo3-fluorescence. As illustrated in 
Fig. 3, a 48 hours exposure to nocodazole increased the Fluo3-fluorescence, an effect reaching 
statistical significance at 60 µg/ml nocodazole. In order to test whether the stimulation of cell membrane scrambling by nocodazole requires the entry of extracellular Ca2+, erythrocytes were incubated for 48 hours in the absence or presence of 60 µg/ml nocodazole in the presence or nominal absence of extracellular Ca2+. As shown in Fig. 4, removal of extracellular Ca2+ significantly blunted the effect of nocodazole on annexin-V-binding. Nevertheless, even in the absence extracellular Ca2+ nocodazole significantly increased the percentage of annexin-V-binding erythrocytes. Thus, nocodazole-induced cell membrane scrambling was in part but not fully due to entry of extracellular Ca2+. Neither in the presence nor in the absence of extracellular Ca2+ did nocodazole significantly modify average forward scatter. 
To test whether a 48 hours incubation with nocodazole modified the effect of excessive [Ca2+]i on cell membrane scrambling or forward scatter, erythrocytes were exposed for 60 min to Ca2+ ionophore ionomycin (1 µM). As a result, ionomycin increased the percentage of annexin-V-binding erythrocytes to similarly high levels in erythrocytes incubated with nocodazole (from 4.8 ± 0.3% to 35.8 ± 1.6% n = 4) and in erythrocytes incubated without nocodazole (from 1.6 ± 0.2% to 38.7 ± 1.8% n = 4). Ionomycin decreased the forward scatter to similarly low levels in erythrocytes incubated with nocodazole (from 432 ± 8.8% to 124 ± 1.9%, n = 4) and in erythrocytes incubated without nocodazole (from 440 ± 8.8% to 123 ± 4.4%, n = 4).Additional experiments were performed to elucidate the effect of nocodazole on oxidative stress. Reactive oxygen species (ROS) were estimated utilizing 2′,7′-dichlorodihydrofluorescein (DCF) diacetate. As illustrated in Fig. 5, a 48 hours exposure to nocodazole increased the DCF 
fluorescence, an effect reaching statistical significance at 30 µg/ml nocodazole. 
Fig. 3. Effect of nocodazole on erythrocyte Ca2+ activity. A. Original histogram of Fluo3-fluorescence in erythrocytes following exposure for 48 hours to Ringer solution with solvent DMSO (grey area) and with 
presence of 60 µg/ml nocodazole (black line). B. Arithmetic means ± SEM (n = 8) of the Fluo3-fluorescence (arbitrary units) in erythrocytes exposed for 48 hours to Ringer solution without (white bar) or with (black 
bars) nocodazole (15 – 60 µg/ml). **(p<0.01) indicate significant difference from the absence of nocodazole (ANOVA).
D
ow
nl
oa
de
d 
by
: 
15
9.
14
9.
55
.1
48
 - 
6/
1/
20
16
 3
:5
4:
33
 P
M
Cell Physiol Biochem 2016;38:379-392
DOI: 10.1159/000438638
Published online: January 29, 2016 384
Signoretto et al.: Nocodazole-Induced Eryptosis 
Cellular Physiology 
and Biochemistry
© 2016 The Author(s). Published by S. Karger AG, Basel
www.karger.com/cpb
Eryptosis could further be stimulated by ceramide. Ceramide abundance at the 
erythrocyte surface was thus quantified with flow cytometry utilizing specific antibodies. As 
Fig. 4. Ca2+ sensitivity of nocodazole -induced phosphatidylserine exposure and erythrocyte shrinkage. A,B. Original histogram of annexin-V-binding of erythrocytes following exposure for 48 hours to Ringer solution with solvent DMSO (grey area) and with presence of 60 µg/ml nocodazole (black line) in the presence (A) and absence (B) of extracellular Ca2+. C. Arithmetic means ± SEM (n = 12) of the percentage of annexin-V-binding erythrocytes after a 48 hours treatment with Ringer solution without (white bars) or with (black bars) nocodazole (60 µg/ml) in the presence (left bars, +Ca2+) and absence (right bars, -Ca2+) of Ca2+. D,E. Original histogram of erythrocyte forward scatter following exposure for 48 hours to Ringer solution with solvent DMSO (grey area) and with presence of 60 µg/ml nocodazole (black line) in the presence (D) and absence (E) of extracellular Ca2+. F. Arithmetic means ± SEM (n = 12) of erythrocyte forward scatter after a 48 hours treatment with Ringer solution without (white bars) or with (black bars) nocodazole (60 µg/ml) in the presence (left bars, +Ca2+) and absence (right bars, -Ca2+) of Ca2+. ***(P<0.001) indicates significant 
difference from the absence of nocodazole, #(p<0.05) indicates significant difference from the presence of Ca2+ (ANOVA).
Fig. 5. Effect of nocodazole on erythrocyte ROS formation. A. Original histogram of DCF fluorescence in erythrocytes following exposure for 48 hours to Ringer solution with solvent DMSO (grey area) and with 
presence of 60 µg/ml nocodazole (black line). B. Arithmetic means ± SEM (n = 8) of the DCF fluorescence (arbitrary units) in erythrocytes exposed for 48 hours to Ringer solution without (white bar) or with (black 
bars) nocodazole (15 – 60 µg/ml). ***(p<0.001) indicates significant difference from the absence of no-codazole (ANOVA).
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illustrated in Fig. 6, a 48 hours exposure to nocodazole (60 µg/ml) significantly increased the ceramide abundance.To investigate the effect of nocodazole on tubulin in erythrocytes, TubulinTracker 
reagent was utilized in both flow cytometry and confocal microscopy. As illustrated in Fig. 
7, 48 h treatment of erythrocytes with nocodazole (60 µg/ml) significantly reduced the 
TubulinTracker-dependent fluorescence.To explore whether the stimulation of cell membrane scrambling by nocodazole 
required caspase activity, erythrocytes were exposed for 48 h to 60 μg/ml nocodazole either 
Fig. 6. Effect of nocodazole on ceramide abundance at the erythrocyte surface. A. Original histogram of ceramide abundance in erythrocytes following exposure for 48 hours to Ringer solution with solvent DMSO (grey area) and with presence of 60 µg/ml nocodazole (black line). B. Arithmetic means ± SEM (n = 9) of the ceramide abundance (arbitrary units) in erythrocytes exposed for 48 hours to Ringer solution without 
(white bar) or with (black bars) nocodazole (60 µg/ml). ***(p<0.001) indicates significant difference from the absence of nocodazole (Paired t test).
Fig. 7. Effect of nocodazole on tubulin abundance. A. Confocal images of tubulin abundance in erythrocytes following exposure for 48 hours to Ringer solution with solvent DMSO (left panel) and with presence of 60 µg/ml nocodazole (right panel). B. Arithmetic means ± SEM (n = 4) of the TubulinTracker abundance (arbi-trary units) in erythrocytes exposed for 48 hours to Ringer solution without (white bar) or with (black bars) 
nocodazole (60 µg/ml). *(p<0.05) indicates significant difference from the absence of nocodazole (Paired t test).
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in the absence or presence of the pancaspase inhibitor zVAD (1 μM). As illustrated in Fig. 8, 
zVAD did not significantly modify the effect of nocodazole on annexin-V-binding.
DiscussionThe present observations demonstrate that nocodazole triggers cell membrane scrambling, the key event of suicidal erythrocyte death or eryptosis. The concentrations required for the toxic effect are higher than those required for disassembly of microtubules [13] but are similar to those previously employed to trigger cell cycle arrest [37].   The sensitivity to nocodazole may be particularly high in clinical conditions associated with enhanced eryptosis, such as dehydration [38], hyperphosphatemia [39] chronic kidney disease (CKD) [40-43], hemolytic-uremic syndrome [44], diabetes [45], hepatic failure [46], cardiac failure [47], malignancy [48], sepsis [49], fever [31, 50], sickle-cell disease [31], beta-
thalassemia [31], Hb-C and G6PD-deficiency [31], Wilsons disease [51] as well as advanced age [52]. Moreover, the effect of nocodazole may be compounded by other eryptosis stimulating xenobiotics [38, 39, 41, 48, 53-106]. The stimulation by nocodazole of cell membrane scrambling was in part due to increase of cytosolic Ca2+ activity ([Ca2+]i) and was thus significantly blunted by removal of extracellular Ca2+. However, even in the absence of extracellular Ca2+ nocodazole treatment was followed by stimulation of cell membrane scrambling, pointing to additional mechanisms in the stimulation of eryptosis by nocodazole. Those mechanisms presumably include oxidative stress and ceramide.  
Nocodazole did not significantly modify the average forward scatter but increased the percentage of both, shrunken and swollen erythrocytes. The cell shrinkage could be explained at least partially by increase of [Ca2+]i with subsequent activation of Ca2+ sensitive K+ channels, K+ exit, cell membrane hyperpolarization, Cl- exit and thus cellular loss of KCl with water [32]. The mechanism driving nocodazole induced erythrocyte swelling remains elusive. A candidate mechanism could be impairment of Na+/K+ ATPase with subsequent cellular accumulation of Na+ with Cl-. Whatever mechanism is involved in nocodazole induced cell swelling, it leads to swelling of only a small subset of erythrocytes. We observed a moderate decrease of tubulin abundance following nocodazole treatment. Whether this effect contributes to the stimulation of eryptosis, remains uncertain. In blood platelets Ca2+ induced apoptosis was seemingly insensitive to cytoskeletal rearrangement [107]. The nocodazole induced eryptosis was insensitive to the pancaspase inhibitor zVAD. Accordingly, the stimulation of cell membrane scrambling by nocodazole does apparently 
Fig. 8. Insensitivity of nocodazole in-duced phosphatidylserine exposure to caspase inhibitor zVAD. Arithmetic means ± SEM (n = 9) of the percentage of annex-in-V-binding erythrocytes following in-cubation for 48 hours to Ringer solution without (white bars) or with (black bars) nocodazole (60 µg/ml) treatment in the absence (-zVAD) or presence (+zVAD) of the pancaspase inhibitor zVAD (1 µM). 
***(p<0.001) indicates significant dif-ference from the absence of nocodazole (ANOVA).
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not require caspases.  Suicidal death of nucleated cells may similarly be independent from caspase activation [108-110]. Suicidal cell death may involve activation of other enzymes. Eryptosis, for instance, may involve activation of calpain [31]. Stimulation of eryptosis may lead to anemia due to rapid clearance of eryptosic erythrocytes from circulating blood [31]. Eryptosis further leads to adherence of phosphatdylserine exposing erythrocytes to the vascular wall [111], to stimulation of blood clotting and to triggering of thrombosis [112-114]. Accordingly, enhanced eryptosis may lead to impairment of microcirculation [33, 112, 115-118]. In conclusion, nocodazole triggers eryptosis with cell membrane scrambling, an effect paralleled by and in part due to increase of cytosolic Ca2+ activity, oxidative stress and ceramide. 
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